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Abstract
Iodine is one of the essential bioactive components of the diet which has an effect on the synthesis of the thyroid hor-
mones, and the latter affect proper development and functioning of the organism. If iodide intake is below 50 µg/day, 
the thyroid gland cannot maintain adequate synthesis of thyroid hormones. The 1992/1993 Polish Council for Control 
of Iodine Deficiency Disorders study results were a direct reason for resumption of compulsory table salt iodination. 
Table salt is the commonly used iodine carrier. According to the World Health Organization recommendations, daily salt 
intake should not exceed 5 g of sodium chloride (2 g of sodium) per person. Reduction of dietary sodium intake may 
thus prevent cardiovascular disease. Actions are also being taken to increase the intake of other natural iodine carriers 
(milk, mineral water). Alternative iodine sources in the diet include codfish, Alaska pollock, salmon, eggs, wheat bran, 
broccoli, dried pea seeds, and hazelnuts. Iodination of mineral water and milk, as well as biofortification of the selected 
vegetables and feeding flock and cattle by food rich in iodine should be concerned according to salt restriction diet. It 
is also justified to introduce iodination of mineral water and milk, as well as biofortification of selected vegetables and 
feeding flock and cattle with food rich in iodine to provide adequate iodine intake in the setting of coexisting recommen-
dations to reduce salt intake.
Key words: iodine, diet, arterial hypertension, salt iodination, amiodarone
Folia Cardiologica 2019; 14, 2: 161–165
162
Folia Cardiologica 2019, vol. 14, no. 2
www.journals.viamedica.pl/folia_cardiologica
Introduction
Iodine is one of the essential bioactive components of the 
diet which has an effect on the synthesis of the thyroid 
hormones, and the latter affect proper development and 
functioning of the organism. Iodine is one of the most 
potent antioxidants and has a protective effect in inflam-
matory and malignant processes [1].
Iodine is a dietary constituent that cannot be stored 
in the human body and thus must be consumed in a diet. 
Inadequate iodine intake leads to iodine deficiency, and 
excess intake may result in hyperthyroidism [1, 2].
Dietary recommendations  
regarding iodine intake
The World Health Organization (WHO) recommends the 
following optimal daily iodide intake: 150 µg/day in adult 
subjects, 250 µg/day in pregnant and lactating women, 
50 µg/day in children under 1 year of age, 90 µg/day in 
children at 1–5 years of age, and 120 µg/day in children 
at 6–12 years of age [3]. If iodide intake is below 50 µg/ 
/day, the thyroid gland cannot maintain adequate syn-
thesis of thyroid hormones. This results in a functional 
hypertrophy and structural changes that ultimately lead to 
the development of hypothyroidism. Thyroid hypertrophy 
is potentiated by the lack of thyroid-stimulating hormone 
(TSH) inhibition by the pituitary gland, as TSH is also 
a growth hormone [1].
Thus, it is necessary to maintain adequate iodine 
intake, as its deficiency (and also relatively rarely occur-
ring excess iodine intake) has a negative effect on the 
population health. Prophylactic iodine supplementation 
should be constantly monitored, so its effectiveness can be 
evaluated, and the optimal level of iodine supplementation 
determined [1, 4].
The Polish Council for Control of Iodine Deficiency 
Disorders (PCCIDD) decided to undertake an epidemio-
logical study in 1992–1993 that included schoolchildren, 
neonates, and pregnant women. Results of these studies 
prompted resumption of universal, compulsory salt fortifica-
tion with iodine (20–40 mgKJ/kg) since 1997 [1, 2, 4]. The 
council also determined other indications for prophylactic 
iodine supplementation: additional fortification of infant 
formulas with iodine (10 µg/100 mL of milk) and additional 
iodine supplementation of 150–200 µg/day in pregnant 
and lactating women [1].
This model proved very effective. The prevalence of 
goitre in schoolchildren decreased by 30–80% compared 
to 1992–1993, and in the youngest children (6–8 years of 
age), the prevalence was only 2.6%, i.e., below the endemic 
level [1]. The prevalence of neonatal TSH levels above 
20 µIU/mL decreased from 2.0% to 0.16%, the prevalence 
of goitre in pregnant women decreased from 80% to 19%, 
and a reduction in the prevalence of differentiated thyroid 
cancer in women was observed [1].
In 2002, the Polish model of prophylaxis of iodine de-
ficiency was judged effective and safe. It was found that 
there was no population risk of both hypothyroidism due 
to iodine deficiency and hyperthyroidism due to increased 
iodine intake [1, 3].
It should be noted, however, that this success was 
not absolute. In older children (particularly those in the 
puberty period), goitre is still present in 7–8% depending 
on the region, and the rate of urinary iodine excretion 
above 100 µg/L did not achieve the desired level of 50%. 
No more than 70% of pregnant women receive the re-
commended iodine dose and although the prevalence of 
thyroid cancer in women has decreased, it is progress rate 
of thyroid carcinoma in women is slower its incidence is 
still 3–4 times higher than in 1990. Finally, the quality of 
salt fortification with iodine was estimated at 96% of the 
recommended norm [1, 5].
The National Program to Eliminate Iodine Deficien-
cy-related Abnormalities (Narodowy Program Eliminacji 
Zaburzeń w Przebiegu Niedoboru Jodu) was interrupted in 
2003–2005, reintroduced in 2006 and has been continued 
until present [1].
Reduction of dietary salt intake  
for cardiovascular disease prevention  
and iodine intake
A separate issue is prophylactic iodine supplementation 
in the setting of the recommended reduction of salt 
intake to 5 g/day, as salt is the commonly used carrier 
for iodine.
The WHO recommendations (Paris 2006, Luxembourg 
2007) are based on the established role of salt in increa-
sing the risk of cardiovascular disease including arterial 
hypertension, atherosclerosis, stroke and myocardial infarc-
tion, as well as some malignancies. According to the WHO 
recommendation, daily salt intake should not exceed 5 g of 
sodium chloride (2 g of sodium) per person [6]. The mean 
daily salt intake in Poland is 13.5 g per person, including 
8.8 g of table salt, reaching as much as 15.0 g per person 
in some regions of the country [4].
According to the Standards of Dietary Management in 
Cardiology (Standardy Postępowania Dietetycznego w Kar-
diologii), the 2016 Polish Society of Dietetics statement, 
more than 1 million of deaths annually in the past years 
might be attributed to sodium chloride intake exceeding 
5 g/day, the level recommended by WHO (1.65 million of 
deaths in 2010) [7].
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The World Heart Federation (WHF), European Soc-
iety of Hypertension (ESH), and European Public Health 
Association (EUPHA) report on the effect of sodium 
intake on the incidence of cardiovascular disease in 
low-to-moderate income countries indicates that a reduc-
tion of sodium intake by 1.76 g/day per person results 
in blood pressure lowering by 3.39/1.54 mm Hg [7, 8]. 
Reduction of dietary sodium intake may thus prevent 
cardiovascular disease, in particular hypertension, and 
it may significantly lower elevated blood pressure in 
hypertensive subjects [9].
According to the 2015 Polish Society of Hypertension 
(PTNT, Polskie Towarzystwo Nadciśnienia Tętniczego) 
guidelines, a diet rich in sodium chloride may reduce the 
effectiveness of antihypertensive treatment and thus much 
attention should be paid to reducing salt intake below 5.0 g 
per day in patients with hypertension [8]. It is believed 
that the blood pressure lowering effect of a reduced die-
tary sodium intake is much higher in the elderly patients, 
salt-sensitive subjects, and those with diabetes, metabolic 
syndrome or chronic kidney disease, and thus it may lead 
to a reduction in the number of drugs and their doses in 
such patients [8]
Kypridemos et al. [10] used a microsimulation model 
to evaluate the effect of efforts to reduce sodium chlo-
ride intake in the United Kingdom on the prevention of 
cardiovascular disease. Introduction of a policy to reduce 
sodium chloride intake in 2003–2015 prevented or delayed 
cardiovascular disease in 52,000 persons, and prevented 
10,000 cardiovascular deaths [10].
In view of the above opinions and data, it is important 
to find the right balance between adequate iodine intake 
to allow normal thyroid function and a reduction in salt 
intake recommended by cardiac societies. Of note, salt is 
the main source of iodine in the diet [10].
The National Institute of Food and Nutrition statement 
on efforts to reduce salt intake in Poland has defined the 
directions of these actions, including changes in recipes in 
food industry and catering facilities, increased supervision 
by food safety agencies, and continuation of appropriate 
legislation efforts [7]. These actions should also include 
educational efforts targeted at various groups: consum-
ers, producers, health care and public health institution 
workers, and other groups influencing the lifestyle of the 
population. The PTNT guidelines are also important for 
these efforts, as they recommend salt intake reduction by 
appropriate prevention and promotion initiatives [11]. Of 
note, close cooperation with PCCID is required to introduce 
necessary modifications to the program of prophylactic 
iodine supplementation [8].
The authors of the program were criticised by using 
an undesirable substance as the iodine carrier for prophy-
laxis, as sodium chloride intake is not recommended in 
hypertension and other cardiovascular disease. In addition, 
sodium chloride intake in Poland has been and continues 
to be excessive; only several years ago, intake levels recom-
mended by WHO were exceeded threefold [2].
As noted above, the current sodium chloride intake in 
our country much exceeds the recommended daily intake, 
and thus alternative sources of iodine are needed to provide 
its adequate daily intake. Endocrinologists agree with car-
diologists that nobody should be encouraged to consume 
salt. They are concerned, however, that a further reduction 
in the intake of iodine-fortified salt will have an adverse 
effect on prophylactic iodine supplementation and the epi-
demiology of thyroid disease. The average iodine content 
in 100 g of iodine-fortified table salt is 2293 micrograms 
[12]. To provide the necessary daily iodine intake of 150 µg 
from salt, it is necessary to consume 6.5 g of iodine-fortified 
salt, which exceeds the 5.0 g level recommended by WHO 
[13]. This situation necessitates other solutions that will 
reconcile recommendations of the cardiologists and the 
principles of prophylactic iodine supplementation promot-
ed by endocrinologists. One solution may be to additional 
use of potassium iodate (KIO3) for food fortification with 
iodine [2].
Efforts are being made to increase intake of other nat-
ural iodine carries (milk, mineral water) [14]. A possibility 
to increase iodine content in selected vegetables by their 
biofortification has also been considered [15]. Another 
possible solution is introducing iodine into the food chain 
by feeding flock and cattle with iodine-containing foods.
Drugs and iodine intake
When discussing iodine intake, iodine-containing medi-
cations and contrast agents also need to be mentioned. 
Pharmacological iodine doses (which may exceed daily 
requirement by many times) are present in many sub-
stances used for diagnostic or therapeutic purposes. 
These include radiological contrast agents (containing 
140–400 mg of iodine in 1 mL), disinfectants (iodopo-
vidone — 10 mg of iodine in 1 mL), high-potency Lugol’s 
iodine (127 mg of iodine in 1 mL, i.e., approximately 20 
drops) [16]. Also some antiarrhythmic agents, otherwise 
very effective, particularly amiodarone, may induce thyroid 
dysfunction due to high iodine content (a single 200 mg 
amiodarone tablet contains about 75 mg of iodine). Car-
diac amiodarone dosing may involve administration of 
even several tablets per day, thus largely exceeding daily 
iodine requirement [1]. In addition, the drug accumulates 
in the fat and muscles, and due to a long half-life (about 
100 days), iodine is released also after amiodarone is 
discontinued [16].
Amiodarone has a multidirectional effect on thyroid 
hormone metabolism. Its moiety is similar to that of T4 and 
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perhaps competes with T4 for receptor binding; the drug 
inhibits peripheral monodeiodination of T4 to T3 and in-
duces immune processes in the thyroid [16]. It may induce 
both hypothyroidism (less frequently) and hyperthyroidism 
(more frequently). While hypothyroidism usually develops 
during treatment with amiodarone, hyperthyroidism may 
develop at various times, even several months after the 
drug is discontinued [17]. Radiological contrast agents 
and amiodarone may induce thyrotoxicosis caused by 
destructive thyroiditis [18].
Dietary sources of iodine 
There are only few other health prevention interventions 
that may be considered as effective as the program of 
iodine deficiency prevention that has been in operation 
in Poland for many years [1, 13]. As described above, the 
multiple health benefits of this program are not limited to 
normal endocrine function of the thyroid gland, prevention 
of congenital hypothyroidism, and reduction of neonatal 
mortality in the perinatal period but also include reduction 
in the development of malignancies [19].
Due to the coexisting recommendations to reduce salt 
intake in response to an increasing rates of cardiovascular 
disease, alternative iodine sources are needed to allow 
adequate daily intake. Table 1 shows dietary sources of 
iodine [12].
When recommending a reduction of dietary salt 
intake to the patients, we can also recommend alter-
native iodine sources from other food products, thus 
reconciling apparently incompatible recommendations 
of various societies 
Conclusions
Due to the need for adequate iodine intake to prevent 
thyroid dysfunction, as highlighted by endocrinologists, 
and a recommendation by cardiologists to reduce intake 
of iodinated table salt due to an increased cardiovascular 
disease risk, alternative approaches for providing adequate 
iodine intake are necessary. Thus, it is justified to introduce 
iodination of mineral water and milk, as well as biofortifi-
cation of selected vegetables and feeding flock and cattle 
with food rich in iodine. We should also remember about 
food products that are sources of iodine, so as to include 
them regularly in our menus.
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Table 1. Iodine content in selected food products (based on [12])
Product Iodine content 
[µg/100 g of product]
Fish
Codfish, fresh 110
Alaska pollock, fresh 103
Salmon, fresh 44
Mackerel, smoked 40
Herring, salted/smoked 30
Herring, fresh 24.3
Tuna in oil 25
Flounder, fresh 20
Rainbow trout, fresh 13
Northern pike, fresh 8
Dairy products
‘Rokpol’ cheese, full-fat 40
‘Edamski’ cheese, full-fat 30
Brie cheese, full-fat 11.2
Kefir, 2% fat 7.5
‘Edamski’ melted cheese 7.1
Buttermilk, 0.5% fat 5.9
Eggs
Chicken eggs, whole 9.5
Chicken egg white 6.8
Chicken egg yolk 12
Cereals
Wheat bran 31
Oatmeal 5.9
Rye flakes 5.7
Vegetables
Broccoli 15
Dried pea seeds 13.9
Spinach 12
Radish 8
Dried soy seeds 6.3
Broad beans 6
Nuts
Hazelnuts 17
Peanuts 13
Walnuts 9
Other
White table salt, iodinated 2293
Iodinated mineral water  
‘Ustronianka’
150 µg/L
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Streszczenie
Jod jest pierwiastkiem należącym do niezbędnych bioaktywnych składników diety, który ma udział w syntezie hormo-
nów tarczycy, a te z kolei wpływają na prawidłowy rozwój i funkcjonowanie organizmu. W sytuacji gdy spożycie jodków 
jest mniejsze niż 50 µg/dobę, gruczoł tarczowy nie jest w stanie utrzymać syntezy hormonów tarczycy na prawidłowym 
poziomie. Wyniki badań z lat 1992–1993 Polskiej Komisji ds. Kontroli Zaburzeń z Niedoboru Jodu były bezpośrednim 
powodem powrotu do obowiązkowego jodowania soli kuchennej. Sól kuchenna jest powszechnie stosowanym nośnikiem 
jodu. Zgodnie z zaleceniami Światowej Organizacji zdrowia dzienne spożycie soli nie powinno przekraczać 5 g NaCl 
(2 g Na) na osobę. Kontrolowanie zawartości Na w diecie jest metodą prewencji chorób układu sercowo-naczyniowego. 
Równocześnie są prowadzone działania służące zwiększeniu spożycia innych naturalnych nośników jodu (mleko, woda 
mineralna). Alternatywne źródło jodu w diecie to między innymi dorsz, mintaj, łosoś, jaja, otręby pszenne, brokuły, suche 
nasiona grochu i orzechy laskowe. Zasadna jest idea wdrożenia jodowania wody mineralnej i mleka, a także biofortyfi-
kacji wybranych warzyw oraz podawania jodu trzodzie i bydłu w celu zapewnienia jego odpowiedniej podaży w związku 
z zaleceniami ograniczenia spożycia soli kuchennej.
Słowa kluczowe: jod, dieta, nadciśnienie tętnicze, jodowanie soli, amiodaron
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